Cancer registration in developing countries: luxury or necessity?

The Lancet Oncology

Volumn 9, Issue 2, 2008, Pages 159-167

  Valsecchi, Maria Grazia ^a   Steliarova Foucher, Eva ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ALTERNATIVE MEDICINE; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CULTURAL FACTOR; DEVELOPING COUNTRY; HEALTH BELIEF; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PROGRAM; HOSPITAL INFORMATION SYSTEM; HUMAN RIGHTS; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; LOWEST INCOME GROUP; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; RELIGION; REVIEW; SOCIAL STATUS; STIGMA; TABOO;

COST OF ILLNESS; DEVELOPING COUNTRIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; NEOPLASMS; REGISTRIES;

EID: 38549168431     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70028-7     Document Type: Review

References (68)

1. Leon D., Walt G., and Gilson L. International perspectives on health inequalities and policy. BMJ 322 (2001) 591-594
2. Bray F., and Moller B. Predicting the future burden of cancer. Nat Rev Cancer 6 (2006) 63-74
3. IARC monographs on the evaluation of carcinogenic risks to humans, Vol 83. Tobacco smoke and involuntary smoking. http://monographs.iarc.fr/ENG/Monographs/vol83/volume83.pdf (accessed Nov 22, 2007).
4. Baan R., Straif K., Grosse Y., et al., on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of alcoholic beverages. Lancet Oncol 8 (2007) 292-293
5. In: Vainio H., and Bianchini F. (Eds). IARC Handbooks of cancer prevention Vol 6. Weight control and physical activity (2002), International Agency for Research on Cancer, Lyon
6. In: Riboli E., and Lambert R. (Eds). IARC Scientific Publication no 156. Nutrition and lifestyle: opportunities for cancer prevention (2002), IARCpress, Lyon
7. Parkin D. Cancer in developing countries. Cancer Surveys 19/20 (1994) 519-561
8. Parkin D. International variation. Oncogene 23 (2004) 6329-6340
9. Jones L., Chilton J., Hajek R., et al. Between and within: international perspectives on cancer and health disparities. J Clin Oncol 24 (2006) 2204-2208
10. National Cancer control programmes: policies and managerial guidelines. 2nd edn. (2002), WHO, Geneva
11. Eden T., Pui C.-H., Tognoni G., et al. All children have a right to full access to treatment for cancer. Lancet 364 (2004) 1121-1122
12. In: Parkin D., Whelan S., Ferlay J., et al. (Eds). Cancer incidence in five continents. Vol VIII. IARC Scientific Publication no 155 (2004), IARCPress, Lyon
13. In: Parkin D., Ferlay J., Hamdi-Cherif M., et al. (Eds). Cancer in Africa. Epidemiology and prevention. IARC Scientific Publications no 153 (2003), IARCPress, Lyon
14. Ferlay J., Bray F., Pisani P., and Parkin D. Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no 5. Version 2.0 (2004), IARCPress, Lyon
15. Parkin D. The evolution of population-based cancer registry. Nat Rev Cancer 6 (2006) 603-612
16. Jensen O., and Storm H. Purposes and uses of cancer registration. In: Jensen O., Parkin D., MacLennan R., et al. (Eds). Cancer registration: principles and methods. IARC Scientific Publications no 95 (1991), International Agency for Research on Cancer, Lyon 7-21
17. Parkin D., and Sanghvi L. Cancer registration in developing countries. In: Jensen O., Parkin D., MacLennan R., et al. (Eds). Cancer registration: principles and methods. IARC Scientific Publications no 95 (1991), International Agency for Research on Cancer, Lyon 185-198
18. Masera G., Baez F., Biondi A., et al. North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet 352 (1998) 1923-1926
19. Ribeiro R., Marina N., and Crist W. St Jude Children's Research Hospital International Outreach Program. Leukemia 10 (1996) 570-574
20. Wilimas J., and Ribeiro R. Pediatric hematology-oncology outreach for developing countries. Hematol Oncol Clin North Am 15 (2001) 775-787
21. Antillon F., Baez F., Barr R., et al. AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer 45 (2005) 107-110
22. International Society of Pediatric Oncology (SIOP). Committee on Pediatric Oncology in Developing Countries (PODC). http://www.siop.nl/frameset_achter.asp?p=3 (accessed April 5, 2007).
23. Kennaway E. The data relating to cancer in the publications of the General Register Office. Br J Cancer 4 (1950) 158-172
24. Wood F. Need for cancer morbidity statistics. Am J Publ Health 20 (1930) 11-20
25. Lasch C. Krebskrankenstatistics. Beginn und Aussicht. Z Krebsforschung 50 (1940) 245-298
26. Haenszel W. The United States network of cancer registries. In: Grundmann E., and Pedersen E. (Eds) (1975), Cancer Registry, Springer, Berlin
27. Wagner G. Cancer registration: historical aspects. In: Parkin D., Wagner G., and Muir C. (Eds). The role of the registry in cancer control. IARC Scientific Publications no. 66 (1985), International Agency for Research on Cancer, Lyon 3-12
28. Wagner G. History of cancer registration. In: Jensen O., Parkin D., MacLennan R., et al. (Eds). Cancer registration: principles and methods. IARC Scientific Publications no 95 (1991), International Agency for Research on Cancer, Lyon 3-6
29. Clemmesen J. Statistical studies in the aetiology of malignant neoplasms. Acta Pathol Microbiol Scand 1 suppl (1965) 174
30. Schinz H. Kleine International Krebskonferenz vom 2-6 Sept 1946 in Kopenhagen. Schweiz Med Wochenschr 76 (1946) 1194
31. Stocks P. Cancer registration and studies of incidence by surveys. Bull World Health Organ 20 (1959) 697-715
32. Clemmesen J. Symposium on the Geographical Pathology and Demography of Cancer (1951), Council for the Coordination of International Congresses of Medical Sciences, Paris
33. International Association of Cancer Registries (IACR). http://www.iacr.com.fr/ (accessed April 3, 2007).
34. National Cancer Institute (NCI). http://www.cancer.gov (accessed on April 5, 2007).
35. European Organisation for Research and Treatment of Cancer (EORTC). http://www.eortc.be (accessed April 5, 2007).
36. International Conference on Harmonization (ICH). http://www.ich.org (accessed April 5, 2007).
37. Medical Dictionary for Regulatory Activities (MedDRA). http://www.meddramsso.com (accessed April 5, 2007).
38. IARC. Automated cancer registration. http://www.ukacr.org.uk/encr/ (accessed on April 3, 2007).
39. Chen J.-G., Zhu J., Parkin D., et al. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 119 (2006) 1447-1454
40. Zhu Y., Chen J., and Huang X. Hepatocellular in Qidong County. In: Tang Z., Wu M., and Xia S. (Eds). Primary liver cancer (1989), Springer-Verlag, Beijing 204-222
41. Hsu I., Metcalf R., Welsh J., et al. P53 gene mutational hotspot in human hepatocellular carcinomas from Qidong, China. Nature 350 (1991) 427-428
42. Wang J., Qian G., Zarba A., et al. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 5 (1996) 253-261
43. Chen J. Advances in the etiology and prevention for primary liver cancer. Chin J Cancer Prev Treat 10 (2003) 1121-1125
44. Ming L., Thorgeirsson S., Gail M., et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 36 (2002) 104-110
45. Sun Z., Ming L., Zhu X., and Lu J. Prevention and control of hepatitis B in China. J Med Virol 67 (2003) 447-450
46. Kensler T., Chen J., Egner P., et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthene tetraols in a randomized clinical trial in He Zuo Township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 14 (2005) 2606-2613
47. Wang J., Shen X., He X., et al. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 91 (1999) 347-354
48. Egner P., Wang J., Zhu Y., et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98 (2001) 14601-14606
49. Kensler T., Egner P., Wang J., et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology 127 5 suppl 1 (2004) S310-S318
50. Chen J., Parkin D., Chen Q., et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 10 (2003) 204-209
51. Parkin D., Wabinga H., and Nambooze S. Completeness in an African cancer registry. Cancer Causes Control 12 (2001) 147-152
52. MacLennan R. Items of patient information which may be collected by registries. In: Jensen O., Parkin D., MacLennan R., et al. (Eds). Cancer registration: principles and methods. IARC Scientific Publications no 95 (1991), International Agency for Research on Cancer, Lyon 43-63
53. In: Fritz A., Percy C., Jack A., et al. (Eds). International Classification of Diseases for Oncology. 3rd edn. (2000), WHO, Geneva
54. CanReg, Cancer Registration System. http://www.iacr.com.fr/ (accessed April 5, 2007).
55. Howard S., Marinoni M., Castillo L., et al. Meeting report: improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-part I. Pediatr Blood Cancer 48 (2007) 364-369
56. Valsecchi M., Tognoni G., Bonilla M., et al. Clinical epidemiology of childhood cancer in central America and Caribbean countries. Ann Oncol 15 (2004) 686-688
57. Monza International School of Pediatric Hematology/Oncology (MISPHO). WEBMISPHO. http://www.webmispho.com (accessed April 5, 2007).
58. Pediatric Oncology Networked Database (POND). http://www.pond4kids.org (accessed April 5, 2007).
59. Pediatric Oncology Group of Ontario (POGO). http://www.pogo.ca (accessed April 5, 2007).
60. Ayoub L., Fù L., Pena A., et al. Implementation of a data management program in a pediatric cancer unit in a low incombe country. Pediatr Blood Cancer 49 (2007) 23-27
61. Sankaranarayanan R., Black R., and Parkin D. Cancer survival in developing countries. IARC Scientific Publication no 145 (1998), IARCPress, Lyon
62. Metzger M., Howard S., Fu L., et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 362 (2003) 706-708
63. Breast Health Global Initiative. http://www.fhcrc.org/science/phs/bhgi/ (accessed June 18, 2007).
64. Anderson B., Yip C., Ramsey S., et al., for Global Summit Health Care Systems and Public Policy Panel. Breast J 12 suppl 1 (2006) S54-S69
65. Muir C., Démaret E., and Boyle P. The cancer registry in cancer control: an overview. In: Parkin D., Wagner G., and Muir C. (Eds). The role of the registry in cancer control. IARC Scientific Publications no 66 (1985), International Agency for Research on Cancer, Lyon 3-12
66. World Cancer Declaration. http://www.2006conferences.org/pdfs/DECLARATION_9-18-06.pdf (accessed Jan 9, 2008).
67. Institute of Medicine. Cancer control opportunities in low-and middle income countries (February, 2007). http://www.iom.edu/CMS/3783/23083/40207.aspx (accessed June 18, 2007).
68. Magrath J., and Litvak J. Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst 85 (1993) 862-874